NCT05585073

Brief Summary

Laparoscopic D2 lymph node dissection (LND) for gastric cancer has a wide range of operations and a high degree of difficulty.The purpose of this study was to evaluate the relationship between clinicopathological factors and the difficulty of laparoscopic D2 LND.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
187

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 15, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 18, 2022

Completed
Last Updated

October 18, 2022

Status Verified

October 1, 2022

Enrollment Period

4 months

First QC Date

October 15, 2022

Last Update Submit

October 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • surgery complicated

    Incidence of operative complications between qualified group and unqualified group

    30 days after operation

Study Arms (2)

qualified of D2 Lymph node dissection group

Other: Whether lymph node dissection is qualified or not

not-qualified D2 Lymph node dissection group

Other: Whether lymph node dissection is qualified or not

Interventions

Klass-02-QC LND scale and general error score tool were used to quantitatively evaluate the intraoperative performance of D2 LND

not-qualified D2 Lymph node dissection groupqualified of D2 Lymph node dissection group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The CLASS-01 trial is a prospective multicenter randomized controlled study (ClinicalTrials.gov.number:NCT01609309) to compare the oncological efficacy of laparoscopy and laparotomy in the treatment of locally advanced distal gastric cancer. In this study, 119 patients who underwent laparoscopic surgery at our center who participated in CLASS-01 were selected. All the patients were operated with 2D laparoscopic system.The 2D/3D trial is a prospective clinical trial (ClinicalTrials.gov.number:NCT02327481) that compares the curative effect of 2D and 3D laparoscopic radical gastrectomy in our center. Seventy cases of 2D laparoscopic distal gastrectomy (LDG) were selected

You may qualify if:

  • all patients undergoing laparoscopic surgery
  • Laparoscopic system is 2D and has complete D2 lymph node dissection.

You may not qualify if:

  • patients undergoing laparotomy
  • incomplete video or clinicopathological information

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastric Surgery

Fuzhou, Fujian, China

Location

Related Publications (1)

  • Lu J, Huang JB, Wu D, Xie JW, Wang JB, Lin JX, Zheng CH, Huang CM, Li P. Factors affecting the quality of laparoscopic D2 lymph node dissection for gastric cancer: a cohort study from two randomized controlled trials. Int J Surg. 2023 May 1;109(5):1249-1256. doi: 10.1097/JS9.0000000000000290.

MeSH Terms

Interventions

Nuclear Receptor Subfamily 4, Group A, Member 2

Intervention Hierarchy (Ancestors)

Orphan Nuclear ReceptorsDNA-Binding ProteinsProteinsAmino Acids, Peptides, and ProteinsReceptors, Cytoplasmic and Nuclear

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

October 15, 2022

First Posted

October 18, 2022

Study Start

January 1, 2022

Primary Completion

May 10, 2022

Study Completion

June 20, 2022

Last Updated

October 18, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

Locations